Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

ANP32E promotes the proliferation and glycolysis of melanoma cells by regulating the Wnt/&beta:-catenin pathway

Yun Zhang1, Yannan Jiang2

1Department of Dermatology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu 225012, China; 2Department of Dermatology, The Fourth Affiliated Hospital of Nantong University, The First People’s Hospital of Yancheng, Yancheng, Jiangsu 224000, China.

For correspondence:-  Yannan Jiang   Email: jiangyannan0624@163.com   Tel:+8651588508612

Accepted: 25 November 2021        Published: 30 December 2021

Citation: Zhang Y, Jiang Y. ANP32E promotes the proliferation and glycolysis of melanoma cells by regulating the Wnt/&beta:-catenin pathway. Trop J Pharm Res 2021; 20(12):2475-2480 doi: 10.4314/tjpr.v20i12.3

© 2021 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: This study aimed to explore the related molecular mechanism of acidic leucine-rich nuclear phosphoprotein 32 family member E (ANP32E) in melanoma cell proliferation and glycolysis.
Methods: Quantitative real-time polymerase chain reaction (qRT-PCR) and western blot assays were employed to determine mRNA and protein expression of ANP32E in four melanoma cell lines (A375, G361, SK-MEL-3, and A2058) and normal human immortalized keratinocytes (HACAT), while 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide cell proliferation and clone formation assays were used to detect cell proliferation of A375 cells after ANP32E knockdown. Enzyme-linked immunosorbent assay and western blotting were used to assess the role of ANP32E in glucose consumption and the levels of lactate, adenosine triphosphate (ATP), and glycolytic metabolism-related proteins. Protein expressions of β-catenin and c-Myc in melanoma cells after ANP32E knockdown were determined by Western blotting.
Results: Protein expression and mRNA levels of ANP32E were higher in the four melanoma cell lines than in normal human immortalized keratinocytes (p < 0.001). ANP32E suppression inhibited the proliferation of melanoma cells (p < 0.05). Additionally, ANP32E suppression decreased glucose consumption (p < 0.001), lactate (p < 0.05), ATP (p < 0.001), and glycolytic metabolism-related protein expression in melanoma cells (p < 0.05). Finally, ANP32E was confirmed to regulate Wnt/β-catenin signaling pathway (p < 0.05).
Conclusion: ANP32E promotes the proliferation and glycolysis of melanoma cells by regulating Wnt/β-catenin pathway, thus facilitating the potential discovery of advanced therapeutic targets in melanoma.

Keywords: ANP32E, Melanoma, Wnt, β-catenin, Cell proliferation, Glycolysis

Impact Factor
Thompson Reuters (ISI): 0.523 (2021)
H-5 index (Google Scholar): 39 (2021)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates